Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Feldschreiber

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|March 11, 2009
Public health issues with counterfeit medicinesPeter Feldschreiber
Clinical Pharmacology and Therapeutics|October 23, 2018
Impact of Brexit on UK and EU Drug Regulation and Patient AccessAlasdair Breckenridge, Peter Feldschreiber
British Journal of Clinical Pharmacology|June 7, 2013
Challenges posed to the European pharmaceutical regulatory system by highly personalized medicinesJohn D Johnston, Peter Feldschreiber
Clinical Pharmacology and Therapeutics|June 26, 2019
Response to "Medicines Shortages in the United Kingdom"Alasdair Breckenridge, Peter Feldschreiber
Reviews on Recent Clinical Trials|May 1, 2015
After thalidomide - do we have the right balance between public health and intellectual propertyPeter Feldschreiber, Alasdair Breckenridge
British Journal of Clinical Pharmacology|April 23, 2014
Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal productsJohn D Johnston, Peter Feldschreiber
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Imperfect Intellectual Bridge Between a Master Medicinal Product and Its Associated Custom-Made Medicinal ProductsJohn D Johnston, Peter Feldschreiber
British Journal of Sports Medicine|June 7, 2011
Medicolegal neglect? The case for physical activity promotion and exercise medicineRichard Weiler, Peter Feldschreiber, Emmanuel Stamatakis
British Journal of Clinical Pharmacology|March 13, 2012
Symmetrical analysis of risk-benefitJohn B Warren, Simon Day, Peter Feldschreiber
British Journal of Clinical Pharmacology|July 23, 2014
The medico-legal aspects of prescribing vitamin DJohn S Davies, Chris D Poole, Peter Feldschreiber
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|March 11, 2009
Public health issues with counterfeit medicinesPeter Feldschreiber
Clinical Pharmacology and Therapeutics|October 23, 2018
Impact of Brexit on UK and EU Drug Regulation and Patient AccessAlasdair Breckenridge, Peter Feldschreiber
British Journal of Clinical Pharmacology|June 7, 2013
Challenges posed to the European pharmaceutical regulatory system by highly personalized medicinesJohn D Johnston, Peter Feldschreiber
Clinical Pharmacology and Therapeutics|June 26, 2019
Response to "Medicines Shortages in the United Kingdom"Alasdair Breckenridge, Peter Feldschreiber
Reviews on Recent Clinical Trials|May 1, 2015
After thalidomide - do we have the right balance between public health and intellectual propertyPeter Feldschreiber, Alasdair Breckenridge
British Journal of Clinical Pharmacology|April 23, 2014
Proposal for new European pharmaceutical legislation to permit access to custom-made anti-sense oligonucleotide medicinal productsJohn D Johnston, Peter Feldschreiber
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Imperfect Intellectual Bridge Between a Master Medicinal Product and Its Associated Custom-Made Medicinal ProductsJohn D Johnston, Peter Feldschreiber
British Journal of Sports Medicine|June 7, 2011
Medicolegal neglect? The case for physical activity promotion and exercise medicineRichard Weiler, Peter Feldschreiber, Emmanuel Stamatakis
British Journal of Clinical Pharmacology|March 13, 2012
Symmetrical analysis of risk-benefitJohn B Warren, Simon Day, Peter Feldschreiber
British Journal of Clinical Pharmacology|July 23, 2014
The medico-legal aspects of prescribing vitamin DJohn S Davies, Chris D Poole, Peter Feldschreiber
Pageof 2